法国儿童队列内试验(TwiCs)的方法学、伦理与实施挑战
本文基于法国特发性肾病综合征全国儿童平台的建设经验,评述了队列内试验(TwiCs)在儿科及罕见病领域应用时面临的方法学、伦理与实施复杂性。作者聚焦知情同意、数据质量与可持续性三大挑战,并提出以家庭为中心的电子知情同意、符合互操作标准的真实世界数据基础设施及混合资助策略等实用对策。
要点
- TwiCs将随机对照试验嵌入纵向观察队列,可改善招募与外推性。
- 儿科TwiCs需应对分阶段信息与延迟知情同意的伦理监管难题。
- 长期维持队列试验基础设施需超越短期项目资助的治理与资助模式。
核心结论
- 本评述为团队克服儿科TwiCs实施中的关键伦理、方法学与操作挑战提供了实用策略。
研究设计与样本
- 本文为评述类文章,基于法国特发性肾病综合征全国儿童研究平台的建设经验进行论述。
主要发现
- 作者将关键挑战归纳为知情同意、数据质量与可持续性三个领域。
- 知情同意方面需关注分阶段信息与延迟知情同意带来的伦理和监管挑战。
- 数据质量方面需满足长期、高质量、可互操作且可直接用于研究的临床数据要求。
- 可持续性方面需建立超越短期项目资助的治理与资助模式。
关键数值与推荐
- 可扩展的儿科TwiCs宜采用安全且以家庭为中心的电子知情同意方案。
- 宜建设符合互操作性标准的稳健真实世界数据基础设施。
- 宜采用混合资助策略以维持队列试验基础设施。
临床怎么用
- 在儿科队列中开展嵌入式随机试验时,可优先规划电子知情同意流程以兼顾伦理合规与家庭参与便利。
- 应提前投资可互操作的数据系统,使常规临床数据经规范治理后可用于研究分析。
- 资助规划应把队列视为长期研究基础设施,而非仅依赖短期项目经费。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Trials within Cohorts (TwiCs) provide a pragmatic framework to improve recruitment and external validity by embedding randomized controlled trials within longitudinal observational cohorts. In pediatrics, and particularly in rare diseases, this design is especially attractive but remains difficult to implement in routine practice due to intertwined methodological, ethical, and operational complexities. Building on the development of a national pediatric platform for idiopathic nephrotic syndrome in France, this commentary highlights key challenges and proposes practical strategies to address them. KEY CHALLENGES: We focus on three domains: (i) informed consent, with particular attention to the ethical and regulatory challenges raised by staged information and deferred consent approaches; (ii) data quality, including the long-term requirements for high-quality, interoperable, and research-ready clinical data; and (iii) sustainability, covering governance and funding models needed to maintain a cohort-based trial infrastructure beyond short-term, project-driven grants. PRACTICAL STRATEGIES: We argue that scalable pediatric TwiCs would benefit from secure and family-centered e-consent solutions, robust real-world data infrastructures aligned with interoperability standards, and hybrid funding strategies. CONCLUSIONS: Overall, this commentary offers practical strategies to help teams overcome key ethical, methodological, and operational challenges to implementing pediatric TwiCs. PLAIN LANGUAGE SUMMARY: Trials within Cohorts (TwiCs) represent an innovative approach to clinical research where randomized trials are embedded directly into existing groups of patients, known as cohorts. By using this framework, researchers can ensure that their findings more accurately reflect real-world medical practice. This design is particularly valuable in fields like pediatrics and the study of rare diseases, where the limited number of available patients often makes traditional trial recruitment exceptionally difficult. Despite their potential, implementing TwiCs involves practical complexities that require careful management. One primary challenge involves the information and consent process, as researchers must find ways to properly inform patients and families while complying with strict national ethical and regulatory frameworks. In addition, ensuring the accuracy and seamless sharing of long-term medical data remains a significant technical struggle, as routine clinical data require substantial curation to be "research-ready." There is also the persistent issue of financial sustainability, as traditional funding models often prioritize individual short-term projects rather than the long-term maintenance required to keep a research infrastructure functional over many years. Drawing from experience with a national platform for children with kidney disease in France, several strategic solutions can help overcome these difficulties. Utilizing digital tools such as electronic consent can streamline the enrollment process, improve the delivery of information, and make it more accessible for families to participate. Furthermore, investing in robust and interoperable data systems ensures that high-quality information is consistently available for analysis. Finally, a shift in funding strategy is essential, moving away from temporary grants toward sustained support that recognizes cohorts as vital research infrastructures. By adopting these improvements, TwiCs can become a powerful and efficient tool for evaluating how medical treatments perform in everyday clinical settings.
引用
- Bahans C, Dossier C, Dunand O, et al. Navigating the methodological, ethical, and operational challenges of Trials within Cohorts (TwiCs): insights from a French pediatric research-based cohort. J Clin Epidemiol. 2026. PMID: 41933842. doi:10.1016/j.jclinepi.2026.112260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。